We are going to follow a path in exploring what is causing accelerated bone loss in the patients who come visit us for a hormone analysis. This accelerated bone loss is not the path every person follows, but it is a common path. It is a path of hormone deficiency, runaway inflammation, and gut dysfunction (overload of bad bowel bacteria).
Low hormone levels, inflammation, and bone loss
Low hormone levels and bone loss have been linked together for a long-time. A paper from 2006 (1) that is cited by hundreds of studies offers an introduction to the understanding of the role of hormones and bone loss and the difficulty in managing this problem.
“Estrogen plays a fundamental role in skeletal growth and bone homeostasis in both men and women. Although remarkable progress has been made in our understanding of how estrogen deficiency causes bone loss, the mechanisms involved have proven to be complex and multifaceted. Although estrogen is established to have direct effects on bone cells, recent animal studies have identified additional unexpected regulatory effects of estrogen centered at the level of the adaptive immune response (Inflammation). Furthermore, a potential role for reactive oxygen species (the accelerated breakdown of cells via an impaired immune system – inflammation) has now been identified in both humans and animals.”
We have been treating hormone deficiency for decades. The problems noted in 2006 are the problems we noted in the 1990s and the problems we note today. Patients who come in for hormone assessments have challenges created not only by hormone deficiency, but by chronic uncontrolled inflammation. One of these problems is developing frailty caused by accelerated bone loss.
One of the papers citing this 2006 research is a November 2019 update published in the journal Current osteoporosis reports (2) which suggests:
Estrogen, but not antiresorptive therapies (examples Brand name: Fosamax™, Fosamax™ Plus D) can attenuate (reduce) the inflammatory bone-microenvironment associated with estrogen deficiency. However, already on second year of administration, Menopause Hormone Therapy is associated with excess breast cancer risk, increasing steadily with duration of use.
Menopause Hormone Therapy should be considered in women with premature estrogen deficiency and increased risk of bone loss and osteoporotic fractures. However, Menopause Hormone Therapy use for the prevention of bone loss is hindered by increase in breast cancer risk even in women younger than 60 years old or who are within 10 years of menopause onset.
The increase in breast cancer risk as well as other damaging health risks were noted in the famous 2004 study “Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy: The Women’s Health Initiative Randomized Controlled Trial.”(3) Here the strong recommendation to stop the use of Conjugated Equine Estrogen (Horse estrogen) for chronic disease prevention in postmenopausal women was made. Subsequent research confirmed increasing health safety risks and despite the benefits estrogen could offer is reducing bone fractures and other benefits. The use of horse estrogen hormone or Menopause Hormone Therapy was virtually halted.
At the Magaziner Center for Wellness when suggesting hormone supplementation therapy we suggest the use of Bio-identical hormones. Bio-identical hormones are derived from plant sources (nor pregnant horse urine) and compounded precisely for each patient. These hormones have similar chemical structures as that the human body produces; not an altered or adulterated form as you’ll find in synthetic hormones. We place great emphasis on restoring your hormones back to levels associated with peak performance as gently and naturally as possible.
Estrogen can help with bone loss and reduce fracture risk
Conventional medicine is still trying to find that delicate balance of how to administer horse estrogen safely. Why? Because there are benefits. Here is a June 2020 study: (4)
“Menopausal hormone therapy is effective in preventing menopause-related bone loss and decreasing vertebral, non-vertebral and hip fracture risk. Menopausal hormone therapy contains estrogens that exert both antiosteoclastic (prevents bone breakdown) and osteoanabolic (regrows bone) effects. These effects are dose-dependent, as even ultra-low doses preserve or increase bone mineral density.
Hormone replacement therapy is the treatment of choice to preserve skeletal health in women with premature ovarian insufficiency and early menopause. Menopausal hormone therapy can be considered in women aged under 60 years or within 10 years since menopause as, in this population, benefits outweigh possible risks, such as breast cancer and cardiovascular events.” Again that is if you are using horse estrogens as the therapy. Estrogen in men and women
Effective in men as well
In another recent study, doctors at the University of Arkansas published (5) fascinating insights into how low hormone levels, especially that of estrogen, in maturing men affect their bones. Here are the highlights of their research.
Aging men and women are subject to two distinct types of bone loss mechanisms:
1. low estrogen and
2. oxidative stress.
Bone loss in both sexes are caused by increased osteoclastogenesis (the natural process of bone breakdown that has now accelerated) caused by estrogen deficiency. What this means is that bone cells responsible for breaking down bone so it can be replaced by new bone – is breaking down more bone than can be replaced.
The second cause of bone loss is independent of estrogen deficiency. It is caused by chronic inflammation caused by oxidative stress.
So we are following the path of bone loss. Both men and women are losing bone because:
1) They are low in estrogen and this is preventing replacement or remodeling bone from forming.
2) They are suffering from oxidative stress, chronic inflammation is dissolving their bones.
Inflammation is dissolving bone
Doctors at the University of Florence (6) wrote that negative changes in our body’s antioxidant systems (low antioxidants or nutrients) significantly impacts our ability to make new bone. The researchers recommended that patients with bone loss should be given antioxidants for the treatment and prevention of bone loss as a means to regulate the oxidative stress and the inflammation it causes.As we travel down this patient’s path we have found hormones to be a problem for them, now we find inflammation is a problem for them This is not however where this path ends.
A third independent cause of bone loss – hormone deficiency causes disruption of the Gut Microbiota
Scientists at Emory University and Georgia State University (7) reported that hormone deficiency increases gut permeability (the ability of harmful lipids and other cells to pass through the gut wall into the rest of the body) and the production of osteoclastogenic cytokines (cells that send messages to increase bone destruction through inflammation.)
So in recap – hormone deficiency increases gut inflammation which sends inflammatory messages to the bone marrow to break down bone.
How is this for a summary of this research:
“treatment with probiotics prevents the increase in gut permeability, the production of intestinal and bone marrow cytokines, and the bone loss induced by sex steroid (hormone) depletion.
A 2018 study from Michigan State University (8) had this to say: “There are many studies supporting the role for the microbiome in the regulation of bone health. Direct supplementation of beneficial probiotic bacteria can affect bone health by regulating aspects of gut such as preventing dysbiosis (imbalance) and/or increases in gut permeability and inflammation.”
The path does not end here, especially for men.
Estrogen, progesterone and testosterone – a focus on bone loss in men
Doctors have further suggested a connection between testosterone and estrogen and bone health in aging men. Writing in the journal Bone and Mineral Research, (9) doctors say that estrogen is the dominant regulator of bone metabolism in men and that a legitimate argument can be made that testosterone is largely a prohormone (a building block precursor) for the male skeleton, with its effects on bone mediated principally via aromatization (synthesis) to estrogen.
What does all that mean? It is another example that the balance of hormones in men is equally as challenging to that in women. In the example above the challenges of balancing estrogen and providing enough testosterone in men to help build and maintain bone is highlighted.
Male osteoporosis is a health problem which deserves more attention as nearly 30% of osteoporotic fractures happen in men aged 50 years and above.
Observations from epidemiological studies indicate that elderly men with higher testosterone can preserve their Bone Mass Density better and thus are less prone to fracture.
Observations on men with estrogen resistance or aromatase deficiency indicate that estrogen is equally important in the maintenance of bone health status.
This had been validated in several epidemiological studies which found that the relationships between estrogen and bone health indices are significant and sometimes stronger than testosterone.
Doctors writing in the International Journal of Endocrinology wrote “both testosterone and estrogen are important in the maintenance of bone health in men.”(10)
Doctors at the University of Gothenburg wrote,”Even though estradiol has been considered the ‘female hormone’, levels of serum estradiol in elderly men are higher than those in postmenopausal women. Estradiol levels are more strongly associated with bone mass density, bone turnover and bone loss than testosterone levels are in adult men…” (11)
Doctors at the US Veterans Affairs Medical Center also confirmed that older men with total testosterone or estradiol deficiency were more likely to be osteoporotic. (12)
So Estrogen plays an important role in preventing bone weakening and osteoporosis in men, especially in men over 70.
If you would like to explore more information, please contact our office so we can start a conversation with you.
1 Weitzmann MN, Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest. 2006 May;116(5):1186-94. doi: 10.1172/JCI28550. PMID: 16670759; PMCID: PMC1451218.
2 Stepan JJ, Hruskova H, Kverka M. Update on menopausal hormone therapy for fracture prevention. Current osteoporosis reports. 2019 Dec;17(6):465-73.
3 Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. Jama. 2004 Apr 1;291(14):1701-12.
4 Anagnostis P, Bosdou JK, Vaitsi K, Goulis DG, Lambrinoudaki I. Estrogen and bones after menopause: a reappraisal of data and future perspectives. Hormones. 2020 Jun 9:1-9.
5 Ucer S, Iyer S, Kim HN, et al. The Effects of Aging and Sex Steroid Deficiency on the Murine Skeleton Are Independent and Mechanistically Distinct. J Bone Miner Res. 2016 Oct 7. doi: 10.1002/jbmr.3014.
6 Domazetovic V, Marcucci G, Iantomasi T, Brandi ML, Vincenzini MT. Oxidative stress in bone remodeling: role of antioxidants. Clin Cases Miner Bone Metab. 2017;14(2):209-216.
7 Li JY, Chassaing B, Tyagi AM, Vaccaro C, Luo T, Adams J, Darby TM, Weitzmann MN, Mulle JG, Gewirtz AT, Jones RM. Sex steroid deficiency–associated bone loss is microbiota dependent and prevented by probiotics. The Journal of clinical investigation. 2016 Jun 1;126(6):2049-63.
8 Schepper JD, Irwin R, Kang J, et al. Probiotics in Gut-Bone Signaling. Adv Exp Med Biol. 2017;1033:225-247.
9. Khosla S.Commentary: New Insights Into Androgen and Estrogen Receptor Regulation of the Male Skeleton. J Bone Miner Res. 2015 Apr 9. doi: 10.1002/jbmr.2529.
10 Chin KY, Ima-Nirwana S. Sex steroids and bone health status in men. Int J Endocrinol. 2012;2012:208719. doi: 10.1155/2012/208719. Epub 2012 Oct 24.
11. Vandenput L, Ohlsson C. Estrogens as regulators of bone health in men. Nat Rev Endocrinol. 2009 Aug;5(8):437-43. Epub 2009 Jun 16.
12. Fink HA, Ewing SK, Ensrud KE, Barrett-Connor E, Taylor BC, Cauley JA, Orwoll ES. Association of Testosterone and Estradiol Deficiency with Osteoporosis and Rapid Bone Loss in Older Men. J Clin Endocrinol Metab. 2006 Jul 18